Clinical course of severe and critically ill patients with coronavirus disease 2019 (COVID-19): A comparative study.
作者信息
Chen Luyan, Zhang Bin, Ti Ma-Yi-di-Li Ni-Jia, Yang Ke, Zou Yujian, Zhang Shuixing
机构信息
The First Affiliated Hospital of Jinan University, Guangzhou, Guangdong, China.
The First People's Hospital of Kashi area, Kashi, Xinjiang Uygur Autonomous Region, PR. China.
出版信息
J Infect. 2020 Aug;81(2):e82-e84. doi: 10.1016/j.jinf.2020.05.021. Epub 2020 May 13.
Abstract
摘要
相似文献
1
Clinical course of severe and critically ill patients with coronavirus disease 2019 (COVID-19): A comparative study.2019年冠状病毒病（COVID-19）重症和危重症患者的临床病程：一项对比研究。
J Infect. 2020 Aug;81(2):e82-e84. doi: 10.1016/j.jinf.2020.05.021. Epub 2020 May 13.
2
Mobile X-rays are highly valuable for critically ill COVID patients.移动X光机对危重症新冠患者非常有价值。
Eur Radiol. 2020 Sep;30(9):5217-5219. doi: 10.1007/s00330-020-06918-2. Epub 2020 May 13.
3
Response to 'Impact of immunosuppression on mortality in critically ill COVID-19 patients'.对《免疫抑制对危重症COVID-19患者死亡率的影响》的回应
Br J Haematol. 2020 Nov;191(3):505-506. doi: 10.1111/bjh.17110. Epub 2020 Oct 26.
4
Critically ill patients with COVID-19 and candidaemia: We must keep this in mind.患有 COVID-19 和念珠菌血症的重症患者：我们必须牢记这一点。
J Mycol Med. 2020 Dec;30(4):101012. doi: 10.1016/j.mycmed.2020.101012. Epub 2020 Jul 4.
5
Cluster of chalazia in nurses using eye protection while caring for critically ill patients with COVID-19 in intensive care.在重症监护病房护理新冠肺炎重症患者时使用眼部防护的护士中出现睑板腺囊肿群。
Occup Environ Med. 2020 Aug;77(8):584-585. doi: 10.1136/oemed-2020-106677. Epub 2020 May 28.
6
Impactful Policy Action to Reduce Drug Costs in Managing Critically Ill Patients with COVID-19.降低新冠肺炎重症患者治疗药物成本的有效政策行动
Mayo Clin Proc. 2020 Aug;95(8):1808-1809. doi: 10.1016/j.mayocp.2020.06.042. Epub 2020 Jun 30.
7
Comment to: Intensive support recommendations for critically-ill patients with suspected or confirmed COVID-19 infection.对《疑似或确诊新型冠状病毒肺炎感染重症患者的强化支持建议》的评论
Einstein (Sao Paulo). 2020;18:eCE5931. doi: 10.31744/einstein_journal/2020ce5931. Epub 2020 Aug 5.
8
Early administered antibiotics do not impact mortality in critically ill patients with COVID-19.早期使用抗生素对新冠肺炎危重症患者的死亡率没有影响。
J Infect. 2020 Aug;81(2):e148-e149. doi: 10.1016/j.jinf.2020.06.004. Epub 2020 Jun 5.
9
Family Member Visits to Critically Ill Patients During COVID-19: A New Pathway.新冠疫情期间家庭成员对重症患者的探访：一条新途径。
Telemed J E Health. 2020 Jul;26(7):853-854. doi: 10.1089/tmj.2020.0097. Epub 2020 Apr 21.
10
Study of critically ill patients with COVID-19 in New York City.纽约市新冠肺炎危重症患者的研究。
Lancet. 2020 Oct 10;396(10257):1064. doi: 10.1016/S0140-6736(20)32072-9.
引用本文的文献
1
Survival Analysis of Hospital Length of Stay of COVID-19 Patients in Ilam Province, Iran: A Retrospective Cross-Sectional Study.伊朗伊拉姆省新冠肺炎患者住院时间的生存分析：一项回顾性横断面研究
J Clin Med. 2023 Oct 23;12(20):6678. doi: 10.3390/jcm12206678.
2
Prognosing the risk of COVID-19 death through a machine learning-based routine blood panel: A retrospective study in Brazil.基于机器学习的常规血液检测预测 COVID-19 死亡风险：巴西的一项回顾性研究。
Int J Med Inform. 2022 Sep;165:104835. doi: 10.1016/j.ijmedinf.2022.104835. Epub 2022 Jul 27.
3
Clinicoepidemiological profile of COVID-19 patients admitted at a teaching institute in a hilly area of India during the second wave-A retrospective observational study.印度山区一所教学机构收治的新冠病毒病患者在第二波疫情期间的临床流行病学特征——一项回顾性观察研究
J Family Med Prim Care. 2022 May;11(5):2172-2178. doi: 10.4103/jfmpc.jfmpc_2251_21. Epub 2022 May 14.
4
Efficacy and safety of pegylated interferon-α2b in moderate COVID-19: a phase 3, randomized, comparator-controlled, open-label study.聚乙二醇干扰素-α2b 在中度 COVID-19 中的疗效和安全性：一项 3 期、随机、对照、开放标签研究。
Int J Infect Dis. 2021 Oct;111:281-287. doi: 10.1016/j.ijid.2021.08.044. Epub 2021 Aug 21.
5
Gastroenterology manifestations and COVID-19 outcomes: A meta-analysis of 25,252 cohorts among the first and second waves.胃肠病学表现和 COVID-19 结局：第一波和第二波中 25252 个队列的荟萃分析。
J Med Virol. 2021 May;93(5):2740-2768. doi: 10.1002/jmv.26836. Epub 2021 Feb 23.
6
Clinical Characteristics, Treatment, and Outcomes of Critically Ill Patients With COVID-19: A Scoping Review.《COVID-19 重症患者的临床特征、治疗和结局：范围综述》
Mayo Clin Proc. 2021 Jan;96(1):183-202. doi: 10.1016/j.mayocp.2020.10.022. Epub 2020 Oct 26.
7
Clinical characteristics and outcomes of critically ill patients with COVID-19 admitted to an intensive care unit in London: A prospective observational cohort study.伦敦一家重症监护病房收治的 COVID-19 危重症患者的临床特征和转归：一项前瞻性观察性队列研究。
PLoS One. 2020 Dec 15;15(12):e0243710. doi: 10.1371/journal.pone.0243710. eCollection 2020.
8
A survival analysis of COVID-19 in the Mexican population.墨西哥人群 COVID-19 生存分析。
BMC Public Health. 2020 Oct 27;20(1):1616. doi: 10.1186/s12889-020-09721-2.
9
Acute kidney injury and kidney replacement therapy in COVID-19: a systematic review and meta-analysis.2019冠状病毒病中的急性肾损伤及肾脏替代治疗：一项系统评价与荟萃分析
Clin Kidney J. 2020 Sep 2;13(4):550-563. doi: 10.1093/ckj/sfaa160. eCollection 2020 Aug.
本文引用的文献
1
Admission hyperglycemia and radiological findings of SARS-CoV2 in patients with and without diabetes.合并糖尿病与未合并糖尿病的 SARS-CoV2 患者的入院高血糖与放射学表现。
Diabetes Res Clin Pract. 2020 Jun;164:108185. doi: 10.1016/j.diabres.2020.108185. Epub 2020 May 1.
2
Hyperglycemia and the worse prognosis of COVID-19. Why a fast blood glucose control should be mandatory.高血糖与COVID-19的不良预后。为何必须严格控制血糖。
Diabetes Res Clin Pract. 2020 May;163:108186. doi: 10.1016/j.diabres.2020.108186. Epub 2020 Apr 29.
3
Longitudinal Association Between Markers of Liver Injury and Mortality in COVID-19 in China.中国 COVID-19 患者肝损伤标志物与死亡率的纵向关联。
Hepatology. 2020 Aug;72(2):389-398. doi: 10.1002/hep.31301.
4
Risk factors of critical & mortal COVID-19 cases: A systematic literature review and meta-analysis.危重症和死亡 COVID-19 病例的风险因素：系统文献回顾和荟萃分析。
J Infect. 2020 Aug;81(2):e16-e25. doi: 10.1016/j.jinf.2020.04.021. Epub 2020 Apr 23.
5
Treatment With Convalescent Plasma for Critically Ill Patients With Severe Acute Respiratory Syndrome Coronavirus 2 Infection.恢复期血浆治疗严重急性呼吸综合征冠状病毒 2 感染的危重症患者。
Chest. 2020 Jul;158(1):e9-e13. doi: 10.1016/j.chest.2020.03.039. Epub 2020 Mar 31.
6
Planning and provision of ECMO services for severe ARDS during the COVID-19 pandemic and other outbreaks of emerging infectious diseases.COVID-19 大流行期间和其他新发传染病疫情中严重急性呼吸窘迫综合征的体外膜肺氧合服务规划和供应。
Lancet Respir Med. 2020 May;8(5):518-526. doi: 10.1016/S2213-2600(20)30121-1. Epub 2020 Mar 20.
7
Characteristics of and Important Lessons From the Coronavirus Disease 2019 (COVID-19) Outbreak in China: Summary of a Report of 72 314 Cases From the Chinese Center for Disease Control and Prevention.中国2019年冠状病毒病（COVID-19）疫情的特征及重要经验教训：来自中国疾病预防控制中心72314例病例报告的总结
JAMA. 2020 Apr 7;323(13):1239-1242. doi: 10.1001/jama.2020.2648.
8
Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study.中国武汉 99 例 2019 年新型冠状病毒肺炎患者的流行病学和临床特征：描述性研究。
Lancet. 2020 Feb 15;395(10223):507-513. doi: 10.1016/S0140-6736(20)30211-7. Epub 2020 Jan 30.
Zotero 插件